tuberous sclerosis complex (TSC), and CDKL5 deficiency disorder (CDD). A phase 3 trial in Dravet's, called DEEp SEA, started last month. Earlier this year, Longboard reported encouraging results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback